RohitSinghMD
Oncology • Burlington, VTMelanoma, Thoracic Cancer
Assistant Professor, Division of Hematology Oncology, Larner College of Medicine University of Vermont Cancer Center
Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Burlington, VT 05401Phone+1 802-847-8400
Summary
- As a dedicated medical oncologist with a specialization in immuno-oncology, I am passionate about improving the lives of patients battling thoracic and cutaneous cancers. My journey in medicine began in India, where I laid the foundation for my career. I then advanced my expertise through an internal medicine residency at the Yale University Waterbury Center in Connecticut. Following this, I completed a rigorous hematology-oncology fellowship at the University of Vermont, where I honed my skills and deepened my commitment to patient care. Today, I am proud to continue my practice here, where I strive to make a meaningful difference in the lives of those I treat.
Education & Training
Pt. B.D. Sharma Postgrad Institute of Medical ScienceClass of 2015, MD
Certifications & Licensure
VT State Medical License 2024 - 2026
CT State Medical License 2023 - 2024
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Merit award for an abstract ESMO, 2023
- Editorial fellow Journal of Clinical Oncology, 2023
- Intern of the Year Yale-Waterbury medicine residency, 2019
Publications & Presentations
PubMed
- Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review.Simran Kalsi, Amanda L Galenkamp, Rohit Singh, Atulya Aman Khosla, Peter McGranaghan
Current Oncology Reports. 2024-12-01 - BIO24-029: Predicting Disparities in Adverse Dispositions Following Major Surgery for Lung Cancer Using Machine Learning.Atulya Aman Khosla, Vijval Rajan, Mohammad Arfat Ganiyani, Nitya Batra, Karan Jatwani
Journal of the National Comprehensive Cancer Network. 2024-04-05 - Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies.Mandy Jongbloed, Atulya A Khosla, Valentina Bartolomeo, Karan Jatwani, Rohit Singh
Current Oncology Reports. 2024-01-01
Press Mentions
JCO Article Insights: Atezolizumab plus Bevacizumab, Chemotherapy in EGFR, ALK NSCLCApril 29th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
